Tag: Diabetes: Type II
Pioglitazone Associated With Lower Blood Leptin in Diabetes
In T2DM, leptin levels are lower with pioglitazone than placebo but not oral antidiabetic drugs
DPP-4 Inhibitor Has Dissociated Effects on β-Cell Function
Single dose of sitagliptin linked to increases in standardized insulin secretion, active GIP, GLP-1
Intensive BP Goals Reduce Risk of Cardiovascular Events
Benefits similar in patients with and without type 2 diabetes
Pre-Op Liraglutide Cuts Post-Op Plasma Glucose in T2DM
Preoperative administration of liraglutide linked to lower post-op glucose, increase in pre-op nausea
Expanded TIMI Risk Score Deemed Practical in Diabetes
Atherothrombotic disease risk assessment based upon 10 readily available clinical variables
Stricter Short-Term Glycemic Control May Increase Remission
Findings among newly diagnosed diabetes patients undergoing short-term intensive insulin therapy
Measuring Quality of Life Important With Diabetes Tx
Predictors of patient-reported outcomes vary by outcome examined
β-Cell Sensitivity to Glucose Impaired After Gastric Bypass
Individuals with prior Roux-en-Y gastric bypass have reduced β-cell glucose sensitivity
Program Aids Quality of Life for Older Adults With T2DM
Intervention includes in-home nurse visits, wellness program, care coordination
FDA Approves Ozempic for Type 2 Diabetes
Novo Nordisk drug also found to help with weight loss
